Showing results (471-480 of 513) with videos related to

Sort By:
Pageof 52
Gastroenterology|December 16, 2014
Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processesKalliope N Diakopoulos, Marina Lesina, Sonja Wörmann, et al.
Gut|May 12, 2025
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancerThomas Rösner, Carina Rupp, Christian Lechler, et al.
Hepatology (Baltimore, Md.)|February 20, 2016
Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein responseYoshiaki Sunami, Marc Ringelhan, Enikö Kokai, et al.
The New England Journal of Medicine|January 6, 2012
TFAP2E-DKK4 and chemoresistance in colorectal cancerMatthias P A Ebert, Marc Tänzer, Benjamin Balluff, et al.
Cancer Cell|July 13, 2013
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic interventionRoland Rad, Juan Cadiñanos, Lena Rad, et al.
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
JCI Insight|April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtypeFelix Orben, Katharina Lankes, Christian Schneeweis, et al.
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 26, 2025
Loss of FXR or Bile Acid-dependent Inhibition Accelerate Carcinogenesis of Gastroesophageal AdenocarcinomaTheresa Baumeister, Andrea Proaño-Vasco, Amira Metwaly, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 23, 2019
BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinomaMaria Wiethaler, Julia Slotta-Huspenina, Anna Brandtner, et al.
Pageof 52